SCHEMBL4008570

SCHEMBL4008570

OCCOCCCOC(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.52
HRH4 Q9H3N8 1/20 0.44
TK2 O00142 7/20 0.40
DUT P33316 1/20 0.39
SLC6A1 P30531 1/20 0.39
TK1 P04183 1/20 0.39
ALDH1A1 P00352 1/20 0.38
RECQL P46063 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
TSHR P16473 3/20 0.36
CYP2C9 P11712 1/20 0.36
ALOX15 P16050 1/20 0.36
CYP2C19 P33261 1/20 0.36
PPARG P37231 1/20 0.36
MAPK1 P28482 1/20 0.36
KCNH3 Q9ULD8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4455872 0.95 KIF11 (0.50) KIF11HRH4TK2DUTSLC6A1
SCHEMBL26176881 0.89 KIF11 (0.55) KIF11HRH4TK2DUTSLC6A1
SCHEMBL26176911 0.89 KIF11 (0.55) KIF11HRH4TK2DUTSLC6A1
SCHEMBL26176883 0.89 KIF11 (0.55) KIF11HRH4TK2DUTSLC6A1
SCHEMBL24207815 0.89 KIF11 (0.55) KIF11HRH4TK2DUTSLC6A1
SCHEMBL24207971 0.89 KIF11 (0.55) KIF11HRH4TK2DUTSLC6A1
SCHEMBL4454711 0.89 KIF11 (0.55) KIF11HRH4TK2DUTSLC6A1
SCHEMBL3190599 0.89 KIF11 (0.55) KIF11HRH4TK2DUTSLC6A1
SCHEMBL2821674 0.89 KIF11 (0.55) KIF11HRH4TK2DUTSLC6A1
SCHEMBL3485522 0.89 KIF11 (0.55) KIF11HRH4TK2DUTSLC6A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2074126-A2 SULFAMOYL-CONTAINING DERIVATIVES AND USES THEREOF Wyeth a Corporation of the State of Delaware (US) 2009-07-01 EP disclosed
US-20080096903-A1 SULFAMOYL-CONTAINING DERIVATIVES AND USES THEREOF WYETH (US) 2008-04-24 US disclosed
WO-2008049105-A2 SULFAMOYL-CONTAINING DERIVATIVES AND USES THEREOF WYETH (US) 2008-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096903-A1 SULFAMOYL-CONTAINING DERIVATIVES AND USES THEREOF HSP90AB2P, HSP90AB1, HSP90AA1 KIF11 3711/4885HRH4 3079/4885TK2 1154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.